% | $
Quotes you view appear here for quick access.

Peregrine Pharmaceuticals, Inc. Message Board

  • choccorrico choccorrico Feb 14, 2013 7:51 PM Flag

    Strange, Zacks changed his buy rating

    to a hold rating, I guess they didn't like the latest news,also at the Fools warnings on PPHM's trial.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Bad guess. They have no interest in paying attention to anything. Do yousrelf a favor and create a new Yahoo email name and sign up for Zacks "reports" or "newsletters" that they advertise at the end of each of their "stories". The truth of what they are all about comes out instantly. They are a clearing house for multiple subscription fee based financial periodicals and advisor newsletters that get thrown in front of you as soon as you sign on. They publish and push their BS "stories" across the news wire with every trick in the book to try to get the attention of all of us to bite, one demographic at a time. When the stock goes up they pump and when the stock goes down they bash! They took a few swipes at PPHM along the way in the process. This latest release is a vanilla flavored bunch of nothing new to gain back some credibility. All IMO of course, but it wont take much to confirm what I said.

0.430.00(+0.84%)Sep 30 4:00 PMEDT